Immunovia AB documents

Explore the latest documents from Immunovia AB, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 28, 2025

Transcript

Slides

Interim report

Q1 2025

May 14, 2025

Transcript

Slides

Interim report

Study Update

Mar 24, 2025

Press release

2024

Q4 2024

Feb 25, 2025

Transcript

Annual report

Slides

Interim report

Study Update

Dec 17, 2024

Slides

Q3 2024

Nov 27, 2024

Slides

Interim report

Q2 2024

Aug 5, 2024

Slides

Interim report

Q1 2024

Apr 29, 2024

Slides

Interim report

2023

Q4 2023

Feb 21, 2024

Annual report

Slides

Earnings release

Q3 2023

Nov 9, 2023

Slides

Interim report

Q2 2023

Aug 30, 2023

Slides

Interim report

Investor Update

Jul 12, 2023

Press release

Q1 2023

May 23, 2023

Slides

Interim report

2022

Q4 2022

Feb 23, 2023

Annual report

Slides

Earnings release

Q3 2022

Nov 10, 2022

Interim report

Q2 2022

Aug 24, 2022

Interim report

Study Result

Jun 27, 2022

Press release

Q1 2022

Apr 28, 2022

Interim report

Slides

2021

Q4 2021

Feb 17, 2022

Annual report

Earnings release

Slides

Q3 2021

Nov 11, 2021

Interim report

Q2 2021

Aug 19, 2021

Interim report

KOL Event 2021

Jun 10, 2021

Press release

Q1 2021

Apr 28, 2021

Report

Study Result

Mar 30, 2021

Slides

2020

Q4 2020

Feb 17, 2021

Annual report

Earnings release

Q3 2020

Nov 12, 2020

Interim report

2019

Q4 2019

Mar 19, 2020

Annual report

2018

Q4 2018

Mar 4, 2019

Annual report

2017

Q4 2017

Mar 19, 2018

Annual report

2016

Q4 2016

Mar 23, 2017

Annual report

2015

Q4 2015

Apr 4, 2016

Annual report